益諾思(688710.SH):公司及全資子公司獲得OECD GLP認證
格隆匯10月8日丨益諾思(688710.SH)公佈,公司及全資子公司益諾思生物技術南通有限公司(簡稱“益諾思南通”)GLP實驗室於近期分別收到匈牙利國家公共衞生和藥品中心(NNGYK)頒佈的GLP證書。本次OECDGLP認證檢查是益諾思上海接受第五次OECDGLP認證檢查,益諾思南通接受第一次OECDGLP認證檢查,公司及全資子公司益諾思南通皆順利獲得了匈牙利國家公共衞生和藥品中心頒佈的OECDGLP認證證書,這標誌着益諾思的質量管理體系已經充分融合了國內國際各監管機構的規範要求,公司及全資子公司益諾思南通均具備了開展符合中國NMPA、美國FDA以及OECDGLP要求的非臨牀藥物安全性評價能力,公司具有競爭力的國際化服務能力得到了進一步的提升。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.